Detection of MGMT promoter methylation in glioblastoma using pyrosequencing

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 2, 2015, Pages 1790-1796

  Xie, Hao ^a   Tubbs, Raymond ^a   Yang, Bin ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Epigenetics; Glioblastoma; Methylation; MGMT; Pyrosequencing

Indexed keywords

DNA LIGASE; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; PARAFFIN; TUMOR SUPPRESSOR PROTEIN;

BRAIN TUMOR; CASE CONTROL STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; ENZYMOLOGY; FINE NEEDLE ASPIRATION BIOPSY; GENETICS; GLIOBLASTOMA; HUMAN; PATHOLOGY; PROCEDURES; PROMOTER REGION; TUMOR CELL LINE;

BIOPSY, FINE-NEEDLE; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GLIOBLASTOMA; HUMANS; PARAFFIN EMBEDDING; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 84928170538     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
2. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350-4.
3. Karayan-Tapon L, Quillien V, Guilhot J, Wager M, Fromont G, Saikali S, Etcheverry A, Hamlat A, Loussouarn D, Campion L, Campone M, Vallette FM, Gratas-Rabbia-Ré C. Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods. J Neurooncol 2010; 97: 311-22.
4. Esteller M, Herman JG. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 2004; 23: 1-8.
5. Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, García-Lopez JL, Piquer J, Safont MJ, Balaña C, Sanchez-Cespedes M, García-Villanueva M, Arribas L, Esteller M. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 2004; 10: 4933-8.
6. Hegi ME. Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide. Clin Cancer Res 2004; 10: 1871-1874.
7. Hegi ME, Diserens AC, Gorlia T. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003.
8. Dunn J, BaboriE A, Alam F, Alam F, Joyce K, Moxham M, Sibson R, Crooks D, Husband D, Shenoy A, Brodbelt A, Wong H, Liloglou T, Haylock B, Walker C. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Brit J Cancer 2009; 101: 124-31.
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Nati Acad Sci U S A 1996; 93: 9821-6.
10. Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res 2006; 34: e78.
11. Mikeska T, Bock C, El-Maarri O, Hübner A, Ehrentraut D, Schramm J, Felsberg J, Kahl P, Büttner R, Pietsch T, Waha A. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007; 9: 368-81.
12. Jha P, Suri V, Jain A, Sharma MC, Pathak P, Jha P, Srivastava A, Suri A, Gupta D, Chosdol K, Chattopadhyay P, Sarkar C. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. Neurosurgery 2010; 67: 1681-91.
13. Derks S, Lentjes MHFM, Hellebrekers DMEI. Methylation-specific PCR unraveled. Cellular Oncologyy 2004; 26: 291-9.